Drugs
-
AB10015, ALS, ALS survival, ALSFRS-R, amyotrophic lateral sclerosis, Drugs, ENCALS, masitinib, mast cells, microglia, motor neuron disease, Neurodegenerative Diseases, neuroscience, riluzole, tyrosine kinase inhibitorMasitinib for ALS: AB10015 Reports 42.3% 5-Year Survival
A 2026 AB10015 post-hoc preprint reported 42.3% 5-year survival from amyotrophic lateral…
-
90-day mortality, acute ischemic stroke, antiseizure medications, Brain, Drugs, epilepsy, levetiracetam, Medicare, neuroscience, older adults, post-stroke seizures, poststroke epilepsy, seizure prophylaxis, target trial emulationLevetiracetam After Stroke: 9 Fewer Deaths in Older Adults
A 2026 Medicare target-trial emulation found continued levetiracetam after acute ischemic stroke…
-
antidepressants, antipsychotics, benzodiazepines, blood screening, clinical toxicology, drug intoxication, Drugs, LC-MS/MS, medication adherence, neuropsychiatric drugs, Psychiatry, serum drug screening77-Drug Blood Screen Found Benzodiazepines in 37.9% of Detections
A 2026 clinical-lab study tested a 77-drug liquid chromatography-tandem mass spectrometry serum…
-
adverse events, antipsychotics, behavioral symptoms of dementia, BPSD, cardiovascular events, cerebrovascular events, Dementia, Drugs, individual participant data meta-analysis, Neurodegenerative Diseases, older adults, Psychiatry, risperidone, side effectsRisperidone in Dementia Raised Stroke-Related Events 4.11x by Week 4
A 2026 individual participant data meta-analysis of 1,721 dementia trial participants linked…
-
AIP4, Alzheimer’s disease, amyloid beta, APP PS1 mice, Brain, cell cycle re-entry, clomipramine, drug repurposing, Drugs, Itch, memory, Neurodegenerative Diseases, neuronal apoptosisClomipramine Improved Alzheimer’s Mouse Memory by Blocking Itch in 45 Days
A 2026 iScience study found that 45 days of clomipramine improved spatial,…
-
adenosine, black tea, caffeine, caffeine timing, coffee, Drugs, PSQI, Psychiatry, Psychology, sleep, sleep disturbances, sleep duration, sleep quality, working adultsCaffeine Intake and Sleep Quality: 428 Working Adults, Source by Source
A 2026 cross-sectional study involving 428 employed adults found that poor sleepers…
-
anti-obesity medication, Diet & Nutrition, Drugs, effort moralization, GLP-1, medication stigma, moral judgment, obesity stigma, Ozempic, Psychology, semaglutide, social psychology, Wegovy, weight stigma, Weight-loss drugsGLP-1 Weight-Loss Drugs Triggered Effort-Based Stigma in 4 Studies
A 2026 Scientific Reports paper involving 1,205 participants found that people using…
-
AD/ADRD, Alzheimer’s disease, APOE-e4, Brain, cardiovascular risk, cognitive decline, Dementia, Drugs, Kaiser Permanente, LDL cholesterol, Neurodegenerative Diseases, observational bias, statins, target trial emulationStatins and Dementia Risk: No Long-Term Signal in 322,358 Patients
Statins do not look like a dementia-prevention drug, but they do not…
-
Immunotherapy could be used to treat depression, early trial suggests
Immunotherapy could be used to treat depression among patients who have not…
-
ADNI, Alzheimer’s disease, amyloid, APOE, APOE-e4, blood biomarker, Brain, cognition, donanemab, Drugs, genetics, lecanemab, longitudinal cohort, mild cognitive impairment, Neurodegenerative Diseases, neuroscience, p-tau217, preclinical ADPlasma p-tau217 Blood Test Predicts Alzheimer’s Risk 1.5x Stronger in APOE-e4
Until recently, Alzheimer’s pathology could only be confirmed in living patients via…
